Former Chief Medical Officer · NovoCure Ltd · Ordinary Shares
Side
SELL
Value
$15K
Shares
1,100
Price
$13.31
Executed
Mar 4, 2026
Disclosed
Mar 5, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 4 executedMar 5, 2026 disclosed
NVCR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Leupin Nicolas filed this Form 4 reporting a open-market sale of NVCR on Mar 4, 2026. It became public on Mar 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Former Chief Medical Officer
Leupin Nicolascik:0002007766
Issuer
NovoCure Ltdcik:0001645113
Revision history · 0
No field has changed since this record was first ingested.
